India, Oct. 6 -- Spectral AI, Inc. (MDAI), a medical diagnostics company, announced that it has submitted a New Technology Add-On Payment (NTAP) application to the Centres for Medicare & Medicaid Services (CMS) for its DeepView System under the alternative pathway.
Spectral AI's DeepView System is a non-invasive, predictive medical device that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of areas within burn wounds.
The DeepView System provides physicians with a data-driven assessment of whether areas within a burn wound are unlikely to heal within 21 days and may require further medical intervention.
The U.S. Food and Drug Administration (FDA) granted it De Novo Classification in May 202...